Pilot experience with continuous infusion alemtuzumab in patients with fludarabine-refractory chronic lymphocytic leukemia.
about
Alemtuzumab for B-cell chronic lymphocytic leukemia.Alemtuzumab by continuous intravenous infusion followed by subcutaneous injection plus rituximab in the treatment of patients with chronic lymphocytic leukemia recurrence.Management of relapsed chronic lymphocytic leukemia: applying guidelines to practiceAlemtuzumab use in relapsed and refractory chronic lymphocytic leukemia: a history and discussion of future rational usePharmacokinetics of alemtuzumab and the relevance in clinical practice.
P2860
Pilot experience with continuous infusion alemtuzumab in patients with fludarabine-refractory chronic lymphocytic leukemia.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Pilot experience with continuo ...... chronic lymphocytic leukemia.
@en
Pilot experience with continuo ...... chronic lymphocytic leukemia.
@nl
type
label
Pilot experience with continuo ...... chronic lymphocytic leukemia.
@en
Pilot experience with continuo ...... chronic lymphocytic leukemia.
@nl
prefLabel
Pilot experience with continuo ...... chronic lymphocytic leukemia.
@en
Pilot experience with continuo ...... chronic lymphocytic leukemia.
@nl
P2093
P2860
P50
P1476
Pilot experience with continuo ...... chronic lymphocytic leukemia.
@en
P2093
Mary L Browning
Ruth LaPushin
Susan M O'Brien
P2860
P304
P356
10.1111/J.1600-0609.2007.01023.X
P577
2007-12-21T00:00:00Z